The Cooper Companies, Inc. $COO Position Trimmed by Thrivent Financial for Lutherans

Thrivent Financial for Lutherans decreased its holdings in The Cooper Companies, Inc. (NASDAQ:COO) by 42.1% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 52,941 shares of the medical device company’s stock after selling 38,459 shares during the quarter. Thrivent Financial for Lutherans’ holdings in Cooper Companies were worth $3,630,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently modified their holdings of COO. Buckhead Capital Management LLC grew its holdings in shares of Cooper Companies by 14.3% during the third quarter. Buckhead Capital Management LLC now owns 58,930 shares of the medical device company’s stock valued at $4,040,000 after buying an additional 7,368 shares in the last quarter. First American Bank acquired a new stake in Cooper Companies during the 3rd quarter worth about $1,646,000. Rakuten Investment Management Inc. acquired a new stake in Cooper Companies during the 3rd quarter worth about $11,341,000. Amundi grew its stake in Cooper Companies by 35.5% during the 2nd quarter. Amundi now owns 1,331,480 shares of the medical device company’s stock valued at $97,225,000 after acquiring an additional 348,652 shares in the last quarter. Finally, Thompson Investment Management Inc. acquired a new position in shares of Cooper Companies in the 3rd quarter valued at about $3,728,000. Institutional investors and hedge funds own 24.39% of the company’s stock.

Insider Buying and Selling at Cooper Companies

In other news, CEO Albert G. White III bought 10,000 shares of the stock in a transaction that occurred on Tuesday, December 16th. The shares were acquired at an average cost of $80.80 per share, for a total transaction of $808,000.00. Following the purchase, the chief executive officer owned 236,151 shares of the company’s stock, valued at $19,081,000.80. This represents a 4.42% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Maria Rivas bought 1,000 shares of the company’s stock in a transaction that occurred on Thursday, December 18th. The stock was purchased at an average price of $82.13 per share, for a total transaction of $82,130.00. Following the acquisition, the director directly owned 11,141 shares in the company, valued at approximately $915,010.33. This trade represents a 9.86% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders purchased 16,014 shares of company stock worth $1,304,416 in the last quarter. 1.98% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

Several analysts recently commented on the stock. Weiss Ratings upgraded shares of Cooper Companies from a “sell (d+)” rating to a “hold (c-)” rating in a report on Monday, January 12th. KeyCorp reissued a “sector weight” rating on shares of Cooper Companies in a research note on Friday, December 5th. Morgan Stanley boosted their price target on shares of Cooper Companies from $76.00 to $83.00 and gave the company an “equal weight” rating in a report on Monday, December 8th. JPMorgan Chase & Co. upped their target price on Cooper Companies from $66.00 to $78.00 and gave the stock a “neutral” rating in a research report on Friday, December 5th. Finally, Robert W. Baird boosted their price target on Cooper Companies from $85.00 to $98.00 and gave the company an “outperform” rating in a research note on Friday, December 5th. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $90.77.

Cooper Companies Stock Performance

COO opened at $82.10 on Monday. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.13 and a current ratio of 1.89. The company has a market cap of $16.09 billion, a PE ratio of 43.67, a price-to-earnings-growth ratio of 2.34 and a beta of 1.03. The stock has a 50-day moving average of $81.37 and a 200-day moving average of $74.54. The Cooper Companies, Inc. has a 52-week low of $61.78 and a 52-week high of $95.43.

Cooper Companies (NASDAQ:COO) last posted its earnings results on Thursday, December 4th. The medical device company reported $1.15 earnings per share for the quarter, topping the consensus estimate of $1.11 by $0.04. The firm had revenue of $1.07 billion during the quarter, compared to analyst estimates of $1.06 billion. Cooper Companies had a return on equity of 10.02% and a net margin of 9.16%.The company’s revenue for the quarter was up 4.6% on a year-over-year basis. During the same period in the previous year, the company earned $1.04 EPS. Cooper Companies has set its FY 2026 guidance at 4.450-4.600 EPS and its Q1 2026 guidance at 1.020-1.040 EPS. As a group, equities research analysts forecast that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.